Chimerism versus minimal residual disease monitoring after allogeneic transplantation--when do we act and will intervention improve outcomes?
作者信息
Pulsipher Michael A
机构信息
Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute/University of Utah School of Medicine, Primary Children's Hospital, Salt Lake City, Utah.
出版信息
Biol Blood Marrow Transplant. 2014 Oct;20(10):1461-2. doi: 10.1016/j.bbmt.2014.07.026. Epub 2014 Jul 29.
PMID:25079876
Abstract
摘要
Zotero 插件